Castleark Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-52,360
| Closed | -$4.29M | – | 326 |
|
|
2024
Q4 | $4.29M | Sell |
52,360
-2,260
| -4% | -$185K | 0.15% | 147 |
|
|
2024
Q3 | $6.24M | Buy |
54,620
+10,930
| +25% | +$1.25M | 0.25% | 91 |
|
|
2024
Q2 | $3.3M | Sell |
43,690
-31,350
| -42% | -$2.37M | 0.13% | 148 |
|
|
2024
Q1 | $5.13M | Sell |
75,040
-10,220
| -12% | -$698K | 0.21% | 113 |
|
|
2023
Q4 | $5.35M | Buy |
85,260
+28,630
| +51% | +$1.8M | 0.24% | 101 |
|
|
2023
Q3 | $2.89M | Sell |
56,630
-12,370
| -18% | -$631K | 0.15% | 144 |
|
|
2023
Q2 | $3.45M | Buy |
+69,000
| New | +$3.45M | 0.16% | 139 |
|